Answers are grounded in this paper and cite their sources.
This review integrates clinical perspectives and cellular biology, proposing targeted therapies for diverse diabetes phenotypes.
Adaptive islet biology and incretin physiology provide a framework linking diverse diabetes phenotypes, with advances in β-cell stress adaptation, intra-islet communication, receptor-resolved biology, and β-cell mass imaging. By integrating clinical perspectives from Asia and Europe with multiscale islet-cell biology, these insights may support mechanism-based and more targeted therapeutic approaches.
No takes yet. Share an insight, caveat, or question.
Murakami et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: